Hopp til innhold
NHI.no
Annonse

Laparoskopisk fundoplikasjon: Forundersøkelser

Innhold i artikkelen

Operasjon er ikke noe man tyr til med en gang ved gastroøsofageal reflukssykdom. Det er kun aktuelt for pasienter med betydelige plager, og der medikamentell behandling ikke hjelper godt nok (etter minst ett år). Man vil noen ganger vurdere inngrepet for yngre mennesker som eventuelt vil ha et langt liv foran seg med disse plagene og med vedvarende medikamentbruk.

Annonse

Forut for operasjon gjøres gastroskopi, det vil si man inspiserer nedre del av spiserøret for å se etter betennelsesforandringer (øsofagitt), tegn til sår eller om det foreligger andre forandringer. Det foretas også 24 timers pH-måling. Det er en undersøkelse der et tynt kateter føres ned i spiserøret via nesen. Tippen på kateteret vil befinne seg nederst i spiserøret, og den inneholder et instrument (en elektrode) som registerer surhetsgraden (pH) i denne delen av spiserøret. En melding om surhetsgraden sendes jevnlig til en liten datamaskin som du bærer på deg i den 24-timers perioden undersøkelsen varer. Ved hjelp av 24 timers pH-måling vil man få klarlagt grad og omfang av syrelekkasje til spiserøret. Enkelte varianter av utstyret som benyttes utfører også trykkmålinger.

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Gastroøsofageal reflukssykdom . Referanselisten for dette dokumentet vises nedenfor

  1. Baird DC, Harker DJ, Karmes AS. Diagnosis and treatment of gastroesophageal reflux in infants and children. Am Fam Physician. 2015 Oct 15;92(8):705-717.
  2. Katzka DA, Kahrilas PJ. Advances in the diagnosis and management of gastroesophageal reflux disease. BMJ. 2020 Nov 23;371:m3786. PMID: 33229333. PubMed
  3. Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal Reflux Disease. JAMA. 2020;324(24):2565. PubMed
  4. Nguyen AD, Spechler SJ, Shuler MN, Souza RF, Dunbar KB. Unique Clinical Features of Los Angeles Grade D Esophagitis Suggest That Factors Other Than Gastroesophageal Reflux Contribute to its Pathogenesis. J Clin Gastroenterol. 2019;53(1):9-14. PubMed
  5. Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018;67(3):430-440.
  6. Chang AB, Lasserson TJ, Gaffney J, et al. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev, issue 1, 2011;CD004823. Cochrane (DOI)
  7. Kahrilas PJ, Howden CW, Hughes N, et al. Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease. Chest 2013 Mar;143(3):605-12 . pmid:23117307. PubMed
  8. Kahrilas PJ. Clinical manifestations and diagnosis of gastroesophageal reflux in adults. UpToDate, last updated Jul 15, 2022. www.uptodate.com
  9. Bujanda DE, Hachem C. Barrett's Esophagus. Mo Med. 2018 May-Jun;115(3):211-213. PMID: 30228724. PubMed
  10. Pandolfino JE. Helicobacter pylori and gastroesophageal reflux disease. UpToDate, last updated Jun 05, 2023. UpToDate
  11. Bytzer P, Jones R, Vakil N, Junghard O, Lind T, Wernersson B, Dent J. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2012;10: 1360-6. PubMed
  12. American Lung Association Asthma Clinical Research Centers, Mastronarde JG, Anthonisen NR, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med. 2009;360:1487-1499. PubMed
  13. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308-328.
  14. Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67(7):1351-1362.
  15. Farrell B, Pottie K, Thompson W et al. Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline. Can Fam Physician. 2017 May;63(5):354-364. PMID: 28500192 PubMed
  16. Katz PO, et al. Guidelines for the diagnosis and management of gastroesophageal reflux disease published correction appears in Am J Gastroenterol. 2013;108(10): 1672. Am J Gastroenterol. 2013;108(3):308–328.
  17. Epstein D, Bojke L, Sculpher MJ. The reflux trial group. Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: a cost effectiveness study. BMJ 2009; 338: b2576. BMJ (DOI)
  18. Grant AM, Boachie C, Cotton SC, et al. Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial). Health Technol Assess 2013 Jun;17(22):1-167. doi: 10.3310/hta17220. DOI
  19. Galømiche J-P, Hatlebakk J, Attwood S, et al. Laparoscopic antireflux surgery vs esomeprazol treatment for chronic GERD. JAMA 2011; 305: 1969-77. Journal of the American Medical Association
  20. Xie Y, Bowe B, Yan Y, et al. Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study. BMJ 2019; 365: l1580. PMID: 31147311 PubMed
  21. Phupong V, Hanprasertpong T. Interventions for heartburn in pregnancy. Cochrane Database of Systematic Reviews 2015, Issue 9. Art. No.: CD011379.pub2 Cochrane (DOI)
  22. Matok I, Gorodischer R, Koren G et al. The safety of H(2)-blockers use during pregnancy. J Clin Pharmacol 2010; 50(1): 81-7. pmid:19789371 PubMed
  23. Gill SK, O'Brien L, Einarson TR, Koren G. The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol 2009; 104(6): 1541. pmid:19491869 PubMed
  24. Hatlebakk JG, Emken BE, Glazkov V, Hoff DA, Hausken T. Correct use of proton pump inhibitors for gastro-oesophageal reflux disease. Tidsskr Nor Laegeforen 2013; 133: 43-46. pmid:23306993 PubMed
  25. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013 Mar;108(3):308-28. PubMed
  26. Sigterman KE, van Pinxteren B, Bonis PA, Lau J, Numans ME. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD002095. DOI: 10.1002/14651858.CD002095.pub5. DOI
  27. Teng M, Khoo AL, Zhao YJ et al. Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection. J Clin Pharm Ther. 2015;40(4):368-75 PubMed
  28. Kang SJ, Jung HK, Tae CH, Kim SY, Lee KJ. On-demand Versus Continuous Maintenance Treatment of Gastroesophageal Reflux Disease With Proton Pump Inhibitors: A Systematic Review and Meta-analysis. J Neurogastroenterol Motil. 2022;28(1):5-14. PubMed
  29. Song H, Zhu J, Lu D. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions. Cochrane Database of Syst Rev 2014; 12: CD010623. doi:10.1002/14651858.CD010623.pub2 DOI
  30. Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017 Mar;152(4):706-15. PubMed
  31. Kiljander TO, Junghard O, Beckman O, Lind T. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med 2010; 181: 1042-8. PubMed
  32. Garg SK, Gurusamy KS. Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev. 2015;(11):CD003243. Cochrane (DOI)
  33. Grant AM, Cotton SC, Boachie C, et al. Minimal access surgery compared with medical management for gastro-oesophageal reflux disease: five year follow-up of a randomised controlled trial (REFLUX). BMJ 2013; 346: f1908. doi:10.1136/bmj.f1908 DOI
  34. American Lung Association Asthma Clinical Research Centers, Mastronarde JG, Anthonisen NR, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med. 2009 Apr 9;360(15):1487-99. PubMed
  35. Shaheen NJ, Falk GW, Iyer PG, Gerson LB; American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol. 2016 Jan;111(1):30-50; quiz 51. Epub 2015 Nov 3. Erratum in: Am J Gastroenterol. 2016 Jul;111(7):1077. PMID: 26526079. PubMed
  36. Maret-Ouda J, Wahlin K, Artama M, et al. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries. JAMA Oncology 2018. doi:10.1001/jamaoncol.2018.3054 DOI
  37. Holmberg D, Santoni G, von Euler-Chelpin M, et al. Non-erosive gastro-oesophageal reflux disease and incidence of oesophageal adenocarcinoma in three Nordic countries: population based cohort study. BMJ 2023; 382: e076017. pmid:37704252 PubMed
  38. Panzuto F, Di GE, Capurso G et al. Large hiatal hernia in patients with iron deficiency anaemia: a prospective study on prevalence and treatment. Aliment Pharmacol Ther 2004; 19: 663-70. PubMed
  39. Zuckerman MJ, Carrion AF. Gastro-oesophageal reflux disease. BMJ Best Practice, last updated 26 Nov, 2019. bestpractice.bmj.com
  40. Kahrilas PJ. Medical management of gastroesophageal reflux disease in adults. UpToDate, last updated Sep 19, 2022. UpToDate
  41. Corazziari ES, Gasbarrini A, D`Alba L, et al. Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial. Am J Gastroenterol. 2023. PMID: 37307528 PubMed
Annonse
Annonse